Exposure of foetal mesencephalic cells to bone morphogenetic protein-2 enhances the survival of dopaminergic neurones in rat striatal grafts

Neuroscience Letters

Volumn 275, Issue 1, 1999, Pages 13-16

  Espejo, Mónica ^a   Cutillas, Blanca ^b   Ventura, Francesc ^a   Ambrosio, Santiago ^a  

^a C ^*  (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bone morphogenetic protein 2; Dopamine; Foetal mesencephalic cells; Neuronal grafts; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

APOMORPHINE; BONE MORPHOGENETIC PROTEIN 2; NEUROTROPHIC FACTOR; OXIDOPAMINE; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BRAIN CELL; BRAIN INJURY; CELL SURVIVAL; CELL TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EMBRYO; MESENCEPHALON; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; RAT; SHORT SURVEY; SUBCUTANEOUS DRUG ADMINISTRATION;

EID: 0032832116     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(99)00708-9     Document Type: Article

References (20)

1. Abrous N., Guy J., Vigny A., Calas M., LeMoal M., Herman J.P. Development of intracerebral dopaminergic grafts: a combined immunohistochemical and autoradiographic study of its time course and environmental influences. J. Comp. Neurol. 273:1988;26-41.
2. Barker R.A., Dunnett S.B., Faissner A., Fawcett J.W. The time course of loss dopaminergic neurons and the gliotic reaction surrounding grafts of embryonic mesencephalon to the striatum. Exp. Neurol. 141:1996;79-93.
3. Brundin P., Duan W.-M., Sauer H. Functional effects of mesencephalic dopamine neurons and adrenal chromaffin cells grafted to the rodent striatum. Dunnett S.B., Björklund A. Functional Neural Transplantation. 1994;9-46 Raven Press, New York.
4. Chen X.L., Roisen F.G., Gupta M. The effect of prior in vitro exposure of donor cells to trophic factors in neurotransplantation. Exp. Neurol. 138:1996;64-72.
5. Dunnett S.B., Björklund A. Staging and dissection of rat embryos. Dunnett S.B., Björklund A. Neural Transplantation - A Practical Approach. 1992;1-19 IRL, Oxford. /57-78.
6. Engele J. Changing responsiveness of developing midbrain dopaminergic neurons for extracellular growth factors. J. Neurosci. Res. 51:1998;508-516.
7. Engele J. Spatial and temporal growth factor influences on developing midbrain dopaminergic neurons. J. Neurosci. Res. 53:1998;405-414.
8. Herman J.P., Abrous N.D. Dopaminergic neural grafts after fifteen years: results and perspectives. Prog. Neurobiol. 44:1994;1-35.
9. Johansson M., Friedemann M., Hoffer B., Strömberg I. Effects of glial cell line-derived neurotrophic factor on developing and mature ventral mesencephalic grafts in oculo. Exp. Neurol. 134:1995;25-34.
10. Jordan J., Büttner M., Schluesener H.J., Unsicker K., Krieglstein K. Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells. Eur. J. Neurosci. 9:1997;1699-1710.
11. Kupsch A., Oertel W.H. Neural transplantation, trophic factors and Parkinson's disease. Life Sci. 55:1994;2083-2095.
12. Mahalik T.J., Hahn W.E., Clayton G.H., Owens G.P. Programmed cell death in developing grafts of foetal substantia nigra. Exp. Neurol. 129:1994;27-36.
13. Massagué J. TGF-β signal transduction. Annu. Rev. Biochem. 67:1998;753-791.
14. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 2nd edn. 1982;Academic Press, New York.
15. Reiriz J., Espejo M., Ventura F., Ambrosio S., Alberch J. Bone morphogenetic protein-2 promotes dissociated effects on the number and differentiation of cultured ventral mesencephalic dopaminergic neurons. J. Neurobiol. 38:1999;161-170.
16. Rosenstein J.M. Why do neural transplants survive? Exp. Neurol. 133:1995;1-6.
17. Söderström S., Bengtsson H., Ebendal T. Expression of serine/threonine kinase receptors including the bone morphogenetic factor type II receptor in the developing and adult rat brain. Cell Tissue Res. 286:1996;269-279.
18. Yurek D.M., Lu W., Hipkens S., Wiegand S.J. BDNF enhances the functional reinnervation of the striatum by grafted foetal dopamine neurons. Exp. Neurol. 137:1996;105-118.
19. Zawada W.M., Zastrow D.J., Clarkson E.D., Adams F.S., Bell K.P., Freed C.R. Growth factors improve immediate survival of embryonic dopamine neurons after transplantation into rats. Brain Res. 786:1998;96-103.
20. Zhang D., Mehler M.F., Song Q., Kessler J.A. Development morphogenetic protein receptors in the nervous system and possible regulating trkC expression. J. Neurosci. 1:1998;3314-3328.